Blood‐based biomarkers and risk of MCI symptom onset over the short and long‐term

Background Blood‐based biomarkers of amyloid and tau have been shown to predict AD‐dementia risk. Much less is known about their ability to predict risk of Mild Cognitive Impairment (MCI) among cognitively normal individuals. It is also unclear how AD non‐specific blood markers of neurodegeneration...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alzheimer's & dementia 2024-12, Vol.20 (S2), p.n/a
Hauptverfasser:	Soldan, Anja, Pettigrew, Corinne, Wang, Jiangxia, Albert, Marilyn S., Blennow, Kaj, Bittner, Tobias, Moghekar, Abhay
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!